A Newspaper for the health conscious


Pinorc Life Science

ACG Inspection joins Verinetics to combat falsified drugs

1 1 1 1 1 1 1 1 1 1 Rating 5.00 (2 Votes)

DTMT Network

ACG Inspection, a Mumbai based supplier that offers manufacturing solutions for the pharma sector, has joined hand with Verinetics, a North-American Company, to fight against substandard drugs with its Traceability and Authenticity solutions in the Track and Trace industry.

Tracking of falsified medicines will be achieved by implementing Multi-Factor Authentication. Multi-Factor Authentication is a security system that requires more than one method of authentication from independent categories of credentials to verify an identity.

TraxSecur, a Verinetics patent-protected software product, will be used for detecting and deterring fraud in the supply chain. Using TraxSecur as a security mark provides intelligent authentication, linked with serialization data. This makes ACG Inspection an end to end solution provider for Track and Trace requirements, product tracing and authentication solutions.

According to a World Health Organization (WHO) report, 1 in 10 medical products in low- and middle-income countries is substandard or falsified.

Mr. Ettore Cucchetti, CEO, ACG Inspection, said that the association will equip consumers with product authentication and ensure genuine products to consumers. Also, it will bring the consumer closer to the pharmaceutical companies, providing first hand feedback about the products.

Dr. Tom Mercolino, CEO Verinetics, said that ACGI has the vision to bring TraxSecur to the pharmaceutical market and deliver its unique benefits as a secure link between items in the physical world and data about those items being tracked in serialization and block chain systems.

“We also applaud ACGI for recognizing the importance of TraxSecur’s multilayered approach for deterring supply chain frauds with overt feature, increasing fraud detection and enforcement effectiveness through it covert features, and how it’s implementation will increase patient trust in their customers’ products,” added Dr Mercolino.

Leave your comments



  • No comments found


  • No comments found
GLS Pharma

Cubit Pharma